title: Deal watch: Galderma pursues 'itchy cytokine' by licensing antibody from Roche's Chugai.
authors: Megan
authors: M
authors: Cully
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D002450:Cell Communication / Q000187:drug effects; D017322:Clinical Trials, Phase II as Topic; D004485:Eczema / Q000188:drug therapy*; D006801:Humans; D007378:Interleukins / Q000037:antagonists & inhibitors*; D011537:Pruritus / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; C502187:IL31 protein, human; D007378:Interleukins